{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:21:44Z","timestamp":1792790504234,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Desjardins scholarship from the Fondation du CHU de Qu\u00e9bec","id":[{"id":"https:\/\/ror.org\/02hj5db43","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1038\/s41380-020-0787-4","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T07:05:52Z","timestamp":1591599952000},"page":"5441-5463","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Shedding a new light on Huntington\u2019s disease: how blood can both propagate and ameliorate disease pathology"],"prefix":"10.1038","volume":"26","author":[{"given":"Marie","family":"Rieux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Alpaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Sciacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Saint-Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Masnata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8na L.","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien A.","family":"L\u00e9vesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Bazenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1450-0949","authenticated-orcid":false,"given":"Alexandre P.","family":"Garneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Isenring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Truant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abid","family":"Oueslati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter V.","family":"Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2312-1257","authenticated-orcid":false,"given":"Anne","family":"Ast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8072-1630","authenticated-orcid":false,"given":"Erich E.","family":"Wanker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5490-1961","authenticated-orcid":false,"given":"Francesca","family":"Cicchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"key":"787_CR1","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/mds.21971","volume":"23","author":"W Phillips","year":"2008","unstructured":"Phillips W, Shannon KM, Barker RA. The current clinical management of Huntington\u2019s disease. Mov Disord. 2008;23:1491\u2013504.","journal-title":"Mov Disord."},{"key":"787_CR2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bandc.2011.07.009","volume":"77","author":"KV Papp","year":"2011","unstructured":"Papp KV, Kaplan RF, Snyder PJ. Biological markers of cognition in prodromal Huntington\u2019s disease: a review. Brain Cogn. 2011;77:280\u201391.","journal-title":"Brain Cogn."},{"key":"787_CR3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2217\/nmt.12.34","volume":"2","author":"C Tang","year":"2012","unstructured":"Tang C, Feigin A. Monitoring Huntington\u2019s disease progression through preclinical and early stages. Neurodegener Dis Manag. 2012;2:421\u201335.","journal-title":"Neurodegener Dis Manag"},{"key":"787_CR4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/B978-0-12-381328-2.00014-6","volume":"98","author":"A Reiner","year":"2011","unstructured":"Reiner A, Dragatsis I, Dietrich P. Genetics and neuropathology of Huntington\u2019s disease. Int Rev Neurobiol. 2011;98:325\u201372.","journal-title":"Int Rev Neurobiol"},{"key":"787_CR5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0072-9752(07)01256-0","volume":"89","author":"JPG Vonsattel","year":"2008","unstructured":"Vonsattel JPG, Keller C, Del Pilar, Amaya M. Neuropathology of Huntington\u2019s disease. Handb Clin Neurol. 2008;89:599\u2013618.","journal-title":"Handb Clin Neurol"},{"key":"787_CR6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1097-2765(04)00151-0","volume":"14","author":"P Venkatraman","year":"2004","unstructured":"Venkatraman P, Wetzel R, Tanaka M, Nukina N, Goldberg AL. Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. Mol Cell. 2004;14:95\u2013104.","journal-title":"Mol Cell."},{"key":"787_CR7","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/10.10.1049","volume":"10","author":"NR Jana","year":"2001","unstructured":"Jana NR, Zemskov EA, Wang G, Nukina N. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Hum Mol Genet. 2001;10:1049\u201359.","journal-title":"Hum Mol Genet"},{"key":"787_CR8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","volume":"90","author":"SW Davies","year":"1997","unstructured":"Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 1997;90:537\u201348.","journal-title":"Cell."},{"key":"787_CR9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00401-016-1582-9","volume":"132","author":"I Jeon","year":"2016","unstructured":"Jeon I, Cicchetti F, Cisbani G, Lee S, Li E, Bae J, et al. Human-to-mouse prion-like propagation of mutant huntingtin protein. Acta Neuropathol 2016;132:577\u201392.","journal-title":"Acta Neuropathol"},{"key":"787_CR10","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1172\/JCI80743","volume":"125","author":"EJ Wild","year":"2015","unstructured":"Wild EJ, Boggio R, Langbehn D, Robertson N, Haider S, Miller JR, et al. Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington\u2019s disease patients. J Clin Investig. 2015;125:1979\u201386.","journal-title":"J Clin Investig"},{"key":"787_CR11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ana.24174","volume":"76","author":"F Cicchetti","year":"2014","unstructured":"Cicchetti F, Lacroix S, Cisbani G, Vallieres N, Saint-Pierre M, St-Amour I, et al. Mutant huntingtin is present in neuronal grafts in Huntington disease patients. Ann Neurol. 2014;76:31\u201342.","journal-title":"Ann Neurol."},{"key":"787_CR12","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jasms.2007.04.012","volume":"18","author":"X Liu","year":"2007","unstructured":"Liu X, Valentine SJ, Plasencia MD, Trimpin S, Naylor S, Clemmer DE. Mapping the human plasma proteome by SCX-LC-IMS-MS. J Am Soc Mass Spectrom. 2007;18:1249\u201364.","journal-title":"J Am Soc Mass Spectrom"},{"key":"787_CR13","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","volume":"19","author":"CA Gutekunst","year":"1999","unstructured":"Gutekunst CA, Li SH, Yi H, Mulroy JS, Kuemmerle S, Jones R, et al. Nuclear and neuropil aggregates in Huntington\u2019s disease: relationship to neuropathology. J Neurosci. 1999;19:2522\u201334.","journal-title":"J Neurosci."},{"key":"787_CR14","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr. Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol. 1985;44:559\u201377.","journal-title":"J Neuropathol Exp Neurol"},{"key":"787_CR15","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou F, Humbert S. The biology of huntingtin. Neuron. 2016;89:910\u201326.","journal-title":"Neuron."},{"key":"787_CR16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.0b013e318282514e","volume":"80","author":"SH Stuwe","year":"2013","unstructured":"Stuwe SH, Goetze O, Lukas C, Klotz P, Hoffmann R, Banasch M, et al. Hepatic mitochondrial dysfunction in manifest and premanifest Huntington disease. Neurology. 2013;80:743\u20136.","journal-title":"Neurol"},{"key":"787_CR17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tcb.2009.01.005","volume":"19","author":"JP Caviston","year":"2009","unstructured":"Caviston JP, Holzbaur ELF. Huntingtin as an essential integrator of intracellular vesicular trafficking. Trends Cell Biol. 2009;19:147\u201355.","journal-title":"Trends Cell Biol"},{"key":"787_CR18","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1172\/JCI64565","volume":"122","author":"A Weiss","year":"2012","unstructured":"Weiss A, Trager U, Wild EJ, Grueninger S, Farmer R, Landles C, et al. Mutant huntingtin fragmentation in immune cells tracks Huntington\u2019s disease progression. J Clin Investig. 2012;122:3731\u20136.","journal-title":"J Clin Investig"},{"key":"787_CR19","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","volume":"205","author":"M Bjorkqvist","year":"2008","unstructured":"Bjorkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N, et al. A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease. J Exp Med. 2008;205:1869\u201377.","journal-title":"J Exp Med"},{"key":"787_CR20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1523\/JNEUROSCI.4846-11.2012","volume":"32","author":"W Kwan","year":"2012","unstructured":"Kwan W, Magnusson A, Chou A, Adame A, Carson MJ, Kohsaka S, et al. Bone marrow transplantation confers modest benefits in mouse models of Huntington\u2019s disease. J Neurosci. 2012;32:133\u201342.","journal-title":"J Neurosci."},{"key":"787_CR21","doi-asserted-by":"crossref","first-page":"a024240","DOI":"10.1101\/cshperspect.a024240","volume":"7","author":"M Jimenez-Sanchez","year":"2017","unstructured":"Jimenez-Sanchez M, Licitra F, Underwood BR, Rubinsztein DC. Huntington\u2019s disease: mechanisms of pathogenesis and therapeutic strategies. Cold Spring Harb Perspect Med. 2017;7:a024240.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"787_CR22","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3389\/fnins.2017.00647","volume":"11","author":"M Masnata","year":"2017","unstructured":"Masnata M, Cicchetti F. The evidence for the spread and seeding capacities of the mutant huntingtin protein in in vitro systems and their therapeutic implications. Front Neurosci. 2017;11:647.","journal-title":"Front Neurosci."},{"key":"787_CR23","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00401-019-01973-6","volume":"137","author":"M Masnata","year":"2019","unstructured":"Masnata M, Sciacca G, Maxan A, Bousset L, Denis HL, Lauruol F, et al. Demonstration of prion-like properties of mutant huntingtin fibrils in both in vitro and in vivo paradigms. Acta Neuropathol. 2019;137:981\u20131001.","journal-title":"Acta Neuropathol."},{"key":"787_CR24","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.molcel.2018.07.032","volume":"71","author":"A Ast","year":"2018","unstructured":"Ast A, Buntru A, Schindler F, Hasenkopf R, Schulz A, Brusendorf L, et al. mHTT seeding activity: a marker of disease progression and neurotoxicity in models of Huntington\u2019s disease. Mol Cell. 2018;71:675\u2013688.e6.","journal-title":"Mol Cell."},{"key":"787_CR25","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.jmb.2018.03.017","volume":"430","author":"AS Wagner","year":"2018","unstructured":"Wagner AS, Politi AZ, Ast A, Bravo-Rodriguez K, Baum K, Buntru A, et al. Self-assembly of mutant huntingtin exon-1 fragments into large complex fibrillar structures involves nucleated branching. J Mol Biol. 2018;430:1725\u201344.","journal-title":"J Mol Biol"},{"key":"787_CR26","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1093\/hmg\/ddy141","volume":"27","author":"J Ko","year":"2018","unstructured":"Ko J, Isas JM, Sabbaugh A, Yoo JH, Pandey NK, Chongtham A, et al. Identification of distinct conformations associated with monomers and fibril assemblies of mutant huntingtin. Hum Mol Genet. 2018;27:2330\u201343.","journal-title":"Hum Mol Genet"},{"key":"787_CR27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.5607\/en.2017.26.6.321","volume":"26","author":"D-K Kim","year":"2017","unstructured":"Kim D-K, Cho K-W, Ahn WJ, Perez-Acu\u00f1a D, Jeong H, Lee H-J, et al. Cell-to-cell transmission of polyglutamine aggregates in C. elegans. Exp Neurobiol. 2017;26:321\u20138.","journal-title":"Exp Neurobiol."},{"key":"787_CR28","doi-asserted-by":"crossref","first-page":"E5427","DOI":"10.1073\/pnas.1516217112","volume":"112","author":"DT Babcock","year":"2015","unstructured":"Babcock DT, Ganetzky B. Transcellular spreading of huntingtin aggregates in the Drosophila brain. Proc Natl Acad Sci. 2015;112:E5427\u201333.","journal-title":"Proc Natl Acad Sci"},{"key":"787_CR29","doi-asserted-by":"crossref","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","volume":"7","author":"LB Menalled","year":"2012","unstructured":"Menalled LB, Kudwa AE, Miller S, Fitzpatrick J, Watson-Johnson J, Keating N, et al. Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175. PLoS One. 2012;7:e49838.","journal-title":"PLoS One."},{"key":"787_CR30","first-page":"50556","volume":"80","author":"P Kamran","year":"2013","unstructured":"Kamran P, Sereti KI, Zhao P, Ali SR, Weissman IL, Ardehali R. Parabiosis in mice: a detailed protocol. J Vis Exp. 2013;80:50556.","journal-title":"J Vis Exp."},{"key":"787_CR31","doi-asserted-by":"crossref","first-page":"e0154398","DOI":"10.1371\/journal.pone.0154398","volume":"11","author":"AP Garneau","year":"2016","unstructured":"Garneau AP, Marcoux A-A, No\u00ebl M, Frenette-Cotton R, Drolet M-C, Couet J, et al. Ablation of potassium-chloride cotransporter type 3 (Kcc3) in mouse causes multiple cardiovascular defects and isosmotic polyuria. PloS One. 2016;11:e0154398.","journal-title":"PloS One."},{"key":"787_CR32","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/jnnp-2018-318854","volume":"90","author":"HL Denis","year":"2019","unstructured":"Denis HL, Lamontagne-Proulx J, St-Amour I, Mason SL, Rowley JW, Cloutier N, et al. Platelet abnormalities in Huntington\u2019s disease. J Neurol Neurosurg Psychiatry. 2019;90:272\u201383.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"787_CR33","doi-asserted-by":"crossref","DOI":"10.1038\/srep35928","volume":"6","author":"G Marcoux","year":"2016","unstructured":"Marcoux G, Duchez A-C, Cloutier N, Provost P, Nigrovic PA, Boilard E. Revealing the diversity of extracellular vesicles using high-dimensional flow cytometry analyses. Sci Rep. 2016;6:35928.","journal-title":"Sci Rep."},{"key":"787_CR34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3233\/JAD-2007-12411","volume":"12","author":"C Tremblay","year":"2007","unstructured":"Tremblay C, Pilote M, Phivilay A, Emond V, Bennett DA, Calon F. Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer\u2019s disease. J Alzheimers Dis. 2007;12:377\u201390.","journal-title":"J Alzheimers Dis"},{"key":"787_CR35","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cll.2007.05.001","volume":"27","author":"JW Tung","year":"2007","unstructured":"Tung JW, Heydari K, Tirouvanziam R, Sahaf B, Parks DR, Herzenberg LA, et al. Modern flow cytometry: a practical approach. Clin Lab Med. 2007;27:453\u201368.","journal-title":"Clin Lab Med"},{"key":"787_CR36","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55:611\u201322.","journal-title":"Clin Chem"},{"key":"787_CR37","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods. 2001;25:402\u20138.","journal-title":"Methods."},{"key":"787_CR38","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/jemt.20829","volume":"73","author":"I Arganda-Carreras","year":"2010","unstructured":"Arganda-Carreras I, Fern\u00e1ndez-Gonz\u00e1lez R, Mu\u00f1oz-Barrutia A, Ortiz-De-Solorzano C. 3D reconstruction of histological sections: application to mammary gland tissue. Microsc Res Technol. 2010;73:1019\u201329.","journal-title":"Microsc Res Technol"},{"key":"787_CR39","volume":"7","author":"JRC Miller","year":"2017","unstructured":"Miller JRC, Pfister EL, Liu W, Andre R, Tr\u00e4ger U, Kennington LA, et al. Allele-selective suppression of mutant huntingtin in primary human blood cells. Sci Rep. 2017;7:46740.","journal-title":"Sci Rep."},{"key":"787_CR40","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","volume":"20","author":"U Shirendeb","year":"2011","unstructured":"Shirendeb U, Reddy AP, Manczak M, Calkins MJ, Mao P, Tagle DA, et al. Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington\u2019s disease: implications for selective neuronal damage. Hum Mol Genet. 2011;20:1438\u201355.","journal-title":"Hum Mol Genet"},{"key":"787_CR41","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","volume":"13","author":"YS Choo","year":"2004","unstructured":"Choo YS, Johnson GVW, MacDonald M, Detloff PJ, Lesort M. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum Mol Genet. 2004;13:1407\u201320.","journal-title":"Hum Mol Genet"},{"key":"787_CR42","first-page":"1948","volume":"23","author":"XL Bu","year":"2017","unstructured":"Bu XL, Xiang Y, Jin WS, Wang J, Shen LL, Huang ZL, et al. Blood-derived amyloid-beta protein induces Alzheimer\u2019s disease pathologies. Mol Psych. 2017;23:1948\u201356.","journal-title":"Mol Psych."},{"key":"787_CR43","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00401-016-1560-2","volume":"131","author":"M Merlini","year":"2016","unstructured":"Merlini M, Wanner D, Nitsch RM. Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer\u2019s disease-related microvascular cerebral amyloid angiopathy. Acta Neuropathol. 2016;131:737\u201352.","journal-title":"Acta Neuropathol."},{"key":"787_CR44","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2202-5-37","volume":"5","author":"O Uspenskaia","year":"2004","unstructured":"Uspenskaia O, Liebetrau M, Herms J, Danek A, Hamann GF. Aging is associated with increased collagen type IV accumulation in the basal lamina of human cerebral microvessels. BMC Neurosci. 2004;5:37.","journal-title":"BMC Neurosci."},{"key":"787_CR45","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.24406","volume":"78","author":"J Drouin-Ouellet","year":"2015","unstructured":"Drouin-Ouellet J, Sawiak SJ, Cisbani G, Lagace M, Kuan WL, Saint-Pierre M, et al. Cerebrovascular and blood-brain barrier impairments in Huntington\u2019s disease: potential implications for its pathophysiology. Ann Neurol. 2015;78:160\u201377.","journal-title":"Ann Neurol."},{"key":"787_CR46","volume":"7","author":"A Di Pardo","year":"2017","unstructured":"Di Pardo A, Amico E, Scalabr\u00ec F, Pepe G, Castaldo S, Elifani F, et al. Impairment of blood-brain barrier is an early event in R6\/2 mouse model of Huntington disease. Sci Rep. 2017;7:41316.","journal-title":"Sci Rep."},{"key":"787_CR47","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, et al. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet. 2003;12:1555\u201367.","journal-title":"Hum Mol Genet"},{"key":"787_CR48","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nbd.2013.08.009","volume":"60","author":"YP Deng","year":"2013","unstructured":"Deng YP, Wong T, Bricker-Anthony C, Deng B, Reiner A. Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington\u2019s disease mice. Neurobiol Dis. 2013;60:89\u2013107.","journal-title":"Neurobiol Dis."},{"key":"787_CR49","first-page":"198","volume":"8","author":"Y-P Deng","year":"2014","unstructured":"Deng Y-P, Wong T, Wan JY, Reiner A. Differential loss of thalamostriatal and corticostriatal input to striatal projection neuron types prior to overt motor symptoms in the Q140 knock-in mouse model of Huntington\u2019s disease. Front Syst Neurosci. 2014;8:198.","journal-title":"Front Syst Neurosci"},{"key":"787_CR50","doi-asserted-by":"crossref","first-page":"180165","DOI":"10.1098\/rsob.180165","volume":"8","author":"Y-T Hsu","year":"2018","unstructured":"Hsu Y-T, Chang Y-G, Chern Y. Insights into GABAAergic system alteration in Huntington\u2019s disease. Open Biol. 2018;8:180165.","journal-title":"Open Biol"},{"key":"787_CR51","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1471-4159.2010.06672.x","volume":"113","author":"I Han","year":"2010","unstructured":"Han I, You Y, Kordower JH, Brady ST, Morfini GA. Differential vulnerability of neurons in Huntington\u2019s disease: the role of cell type-specific features. J Neurochem. 2010;113:1073\u201391.","journal-title":"J Neurochem"},{"key":"787_CR52","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0006-8993(96)00307-1","volume":"730","author":"F Cicchetti","year":"1996","unstructured":"Cicchetti F, Gould PV, Parent A. Sparing of striatal neurons coexpressing calretinin and substance P (NK1) receptor in Huntington\u2019s disease. Brain Res. 1996;730:232\u20137.","journal-title":"Brain Res."},{"key":"787_CR53","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0006-8993(95)00124-9","volume":"674","author":"A Parent","year":"1995","unstructured":"Parent A, Cicchetti F, Beach TG. Calretinin-immunoreactive neurons in the human striatum. Brain Res. 1995;674:347\u201351.","journal-title":"Brain Res."},{"key":"787_CR54","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1097\/00001756-200011270-00032","volume":"11","author":"A van Dellen","year":"2000","unstructured":"van Dellen A, Welch J, Dixon RM, Cordery P, York D, Styles P, et al. N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington\u2019s disease mice. Neuroreport. 2000;11:3751\u20137.","journal-title":"Neuroreport."},{"key":"787_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0891-0618(97)10013-8","volume":"14","author":"J DeFelipe","year":"1997","unstructured":"DeFelipe J. Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex. J Chem Neuroanat. 1997;14:1\u201319.","journal-title":"J Chem Neuroanat"},{"key":"787_CR56","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.molcel.2016.07.022","volume":"63","author":"YE Kim","year":"2016","unstructured":"Kim YE, Hosp F, Frottin F, Ge H, Mann M, Hayer-Hartl M, et al. Soluble oligomers of polyQ-expanded huntingtin target a multiplicity of key cellular factors. Mol Cell. 2016;63:951\u201364.","journal-title":"Mol Cell."},{"key":"787_CR57","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3753","volume":"4","author":"J Leitman","year":"2013","unstructured":"Leitman J, Ulrich Hartl F, Lederkremer GZ. Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress. Nat Commun. 2013;4:2753.","journal-title":"Nat Commun."},{"key":"787_CR58","doi-asserted-by":"crossref","first-page":"E59","DOI":"10.3390\/cells7060059","volume":"7","author":"BL Tang","year":"2018","unstructured":"Tang BL. Unconventional secretion and intercellular transfer of mutant huntingtin. Cells. 2018;7:E59.","journal-title":"Cells"},{"key":"787_CR59","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2017.07.001","volume":"262","author":"D Rufino-Ramos","year":"2017","unstructured":"Rufino-Ramos D, Albuquerque PR, Carmona V, Perfeito R, Nobre RJ, Pereira, de Almeida L. Extracellular vesicles: novel promising delivery systems for therapy of brain diseases. J Controlled Release. 2017;262:247\u201358.","journal-title":"J Controlled Release"},{"key":"787_CR60","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature12481","volume":"501","author":"M Jucker","year":"2013","unstructured":"Jucker M, Walker LC. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature. 2013;501:45\u201351.","journal-title":"Nature."},{"key":"787_CR61","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.cell.2012.05.007","volume":"149","author":"C Soto","year":"2012","unstructured":"Soto C. Transmissible proteins: expanding the prion heresy. Cell. 2012;149:968\u201377.","journal-title":"Cell."},{"key":"787_CR62","doi-asserted-by":"crossref","first-page":"316","DOI":"10.7326\/M15-2421","volume":"165","author":"G Edgren","year":"2016","unstructured":"Edgren G, Hjalgrim H, Rostgaard K, Lambert P, Wikman A, Norda R, et al. Transmission of neurodegenerative disorders through blood transfusion: a cohort study. Ann Intern Med. 2016;165:316\u201324.","journal-title":"Ann Intern Med"},{"key":"787_CR63","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/lt.22174","volume":"16","author":"L Llado","year":"2010","unstructured":"Llado L, Baliellas C, Casasnovas C, Ferrer I, Fabregat J, Ramos E, et al. Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation. Liver Transpl. 2010;16:1386\u201392.","journal-title":"Liver Transpl"},{"key":"787_CR64","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ana.23684","volume":"72","author":"BB Holmes","year":"2012","unstructured":"Holmes BB, Diamond MI. Amyotrophic lateral sclerosis and organ donation: is there risk of disease transmission? Ann Neurol. 2012;72:832\u20136.","journal-title":"Ann Neurol."},{"key":"787_CR65","doi-asserted-by":"crossref","first-page":"e0175968","DOI":"10.1371\/journal.pone.0175968","volume":"12","author":"SR Coffey","year":"2017","unstructured":"Coffey SR, Bragg RM, Minnig S, Ament SA, Cantle JP, Glickenhaus A, et al. Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.HttQ111\/+ mouse model of Huntington\u2019s disease. PloS One 2017;12:e0175968.","journal-title":"PloS One"},{"key":"787_CR66","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","volume":"35","author":"L Menalled","year":"2009","unstructured":"Menalled L, El-Khodor BF, Patry M, Su\u00e1rez-Fari\u00f1as M, Orenstein SJ, Zahasky B, et al. Systematic behavioral evaluation of Huntington\u2019s disease transgenic and knock-in mouse models. Neurobiol Dis. 2009;35:319\u201336.","journal-title":"Neurobiol Dis."},{"key":"787_CR67","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.HYP.14.1.61","volume":"14","author":"W Zidek","year":"1989","unstructured":"Zidek W, Ottens E, Heckmann U. Transmission of hypertension in rats by cross circulation. Hypertension. 1989;14:61\u20135.","journal-title":"Hypertension"},{"key":"787_CR68","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3233\/JHD-160213","volume":"5","author":"JA Bouwens","year":"2016","unstructured":"Bouwens JA, van Duijn E, Cobbaert CM, Roos RAC, van der Mast RC, Giltay EJ. Plasma cytokine levels in relation to neuropsychiatric symptoms and cognitive dysfunction in Huntington\u2019s disease. J Hunt Dis. 2016;5:369\u201377.","journal-title":"J Hunt Dis."},{"key":"787_CR69","doi-asserted-by":"crossref","first-page":"8653132","DOI":"10.1155\/2016\/8653132","volume":"2016","author":"NP Rocha","year":"2016","unstructured":"Rocha NP, Ribeiro FM, Furr-Stimming E, Teixeira AL. Neuroimmunology of Huntington\u2019s disease: revisiting evidence from human studies. Mediators Inflamm. 2016;2016:8653132.","journal-title":"Mediators Inflamm."},{"key":"787_CR70","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nm.3569","volume":"20","author":"SA Villeda","year":"2014","unstructured":"Villeda SA, Plambeck KE, Middeldorp J, Castellano JM, Mosher KI, Luo J, et al. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat Med. 2014;20:659\u201363.","journal-title":"Nat Med."},{"key":"787_CR71","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.12688\/f1000research.11437.1","volume":"6","author":"AM Horowitz","year":"2017","unstructured":"Horowitz AM, Villeda SA. Therapeutic potential of systemic brain rejuvenation strategies for neurodegenerative disease. F1000 Res. 2017;6:1291.","journal-title":"F1000 Res"},{"key":"787_CR72","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jamaneurol.2018.3288","volume":"76","author":"SJ Sha","year":"2019","unstructured":"Sha SJ, Deutsch GK, Tian L, Richardson K, Coburn M, Gaudioso JL, et al. Safety, tolerability, and feasibility of young plasma infusion in the plasma for Alzheimer symptom amelioration study: a randomized clinical trial. JAMA Neurol. 2019;76:35\u201340.","journal-title":"JAMA Neurol"}],"updated-by":[{"DOI":"10.1038\/s41380-020-0850-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T00:00:00Z","timestamp":1595548800000}}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-020-0787-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-020-0787-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-020-0787-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:28:30Z","timestamp":1722990510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-020-0787-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,8]]},"references-count":72,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["787"],"URL":"https:\/\/doi.org\/10.1038\/s41380-020-0787-4","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,8]]},"assertion":[{"value":"7 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2020","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41380-020-0850-1","URL":"https:\/\/doi.org\/10.1038\/s41380-020-0850-1","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}